Health

STAT+: Up and down the ladder: The latest comings and goings

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 23/10/2026, 16:06:24 UTC.

Briefings

STAT+ reported that Callio Therapeutics hired Chris Hassig as chief scientific officer, a move following his tenure at Boundless Bio. The article highlights the company's active recruitment efforts for leadership roles, though it does not specify the hiring timeline or the specific challenges Hassig addressed.

Key points

• Callio Therapeutics hired Chris Hassig as chief scientific officer.
• Hassig previously held the same role at Boundless Bio.

Context

STAT+ features a weekly highlight of personnel changes, noting that Callio Therapeutics actively seeks to fill leadership positions. The article suggests that hiring new leaders is a common strategy for companies facing recruitment challenges.

Limitations

The evidence is limited to the article's headline and introductory text. Specific dates, hiring timelines, or the nature of Hassig's previous work at Boundless Bio are not provided.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 23/10/2026, 16:09:08 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeic3aywt45qnt5bincenoqpsezyhbjdtegbfgjhggjll6asftz5uae